Full List Of Stories
London close: FTSE flops after hawkish Bank of England statement
London's FTSE 100 fell almost 1. 5% on Thursday as the pound spiked higher after the Bank of England signalled that interest rates may rise sooner and higher than it had indicated.
Compass points towards north end of growth targets
Compass guided towards good growth for the full year after a strong start to the year, though the catering group said the first quarter was soured slightly by higher UK cost pressures.
Friday preview: Industrial production, construction and trade in focus
Friday should be quite quiet after recent events, with Victrex the biggest name expected to provide a trading update ahead of UK industrial production numbers later in the morning.
Carney's letter to Chancellor: inflation will be above target for three years
Bank of England Governor Mark Carney has written to Chancellor Philip Hammond to say inflation will remain elevated for several years and that while UK economic growth is likely to grow faster than he expected this year, Brexit could still throw a major spanner in the works.
Debenhams confirms job cuts as part of store restructure
Department store group Debenhams will cut a quarter of store management roles as accelerates its restructuring plans amid the highly challenging UK retail market.
South Africa mines minister calls for industry to 'shape up'
Mining companies in South Africa need to "shape up" and speed transformation towards black ownership or face more pressure for nationalisation, deputy mineral resources minister Godfrey Oliphant has warned.
Thomas Cook ups bookings but faces more margin pain in Spain
Thomas Cook's financial year took off at a steady rate and said but the tour operator said the market remained highly competitive, with continued profits margin pain from increased bed costs in Spain.
Indivior files new lawsuit over Suboxone film
Indivior has filed patent lawsuits in the USA against five rivals for infringing a patent in their respective proposed generic versions of the FTSE 250 company's Suboxone sublingual film product to treat opioid addiction.